Abstract
Objective: To understand, from a narrative review, the possible impacts of SARS-CoV-2 on pregnant women and on fetal development. Bibliographic review: It was found that most pregnant women developed some type of symptom of the disease and the symptoms presented were diverse, with fever and coughing being the most common. The progression of COVID-19 in pregnant women is associated with a coagulopathy process, with a greater possibility of the development of disseminated intravascular clots in the intervillous spaces of the placenta, affecting the gaseous and nutrient exchanges between mother and fetus. Laboratory tests reveal that C-reactive protein may be increased, as well as elevated levels of liver enzymes (TGO and TGP) and elevated creatine phosphokinase, D-dimer and troponin. There is no consistent information to affirm transmission in the maternal-fetal binomial. Final considerations: The symptomatology of pregnant women is similar to that of non-pregnant women and there is no consistent evidence of intrauterine infection caused by vertical transmission in women with SARS-CoV-2 in the third trimester of pregnancy.